Finding new ways to deliver breakthrough treatments. Novartis returns for FH23!
We’re delighted to team up with Novartis once again as they join Frontiers Health 2023 as a silver sponsor!
Novartis is one of the largest pharmaceutical groups in Italy, operating in the country for more than twenty-five years and acting as a major player in innovation in the health area. With its activities increasingly focused on innovative medicines, it plays a leading role in 5 main therapeutic areas: cardiovascular, immunology, neuroscience, solid tumors and hematology. It is also a pioneer in the development of innovative therapeutic platforms, such as radioligands, siRNA and advanced therapies.
Its headquarters are in Milan with a great presence in the country with manufacturing plants: one in Torre Annunziata (Naples), that represents one of the most important production hubs worldwide for cardiovascular drugs and one of the largest pharmaceutical sites in Southern Italy. Another important manufacturing plant is located in Piedmont, where Advanced Accelerator Applications, a Novartis Company, specialized in radiopharmaceuticals, is located.
Learn more about Novartis this November 8-10, in Rome and online!